Who
Paul J. Sekhri
Director
Company insider
Files Form 4 as: Director, Veeva Systems; Director, Apnimed; Pres, CEO and Exec Chairperson, vTv Therapeutics; Director, Longboard Pharmaceuticals; Director, Axcella Health; Director, BiomX; Director, Alpine Immune Sciences; Director, Enumeral Biomedical Holdings.
In numbers
- Trades disclosed
- 185
- Buys
- 4
- Sells
- 18
- Bought
- $534K
- Sold
- $8.4M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 7 Nov 2007
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | VEEV Veeva SystemsSoftware | SEC FORM 4 Code M | —460 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | VEEV Veeva Systemsoption or derivative · Software | SEC FORM 4 Code M | —460 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | VEEV Veeva Systemsoption or derivative · Software | SEC FORM 4 Code M | —460 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | VEEV Veeva SystemsSoftware | SEC FORM 4 Code M | —460 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD ApnimedBiotechnology | SEC FORM 4 Bought | $200K12,500 at $16.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —169,468 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —169,468 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —169,468 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —169,468 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —155,558 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —155,558 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,238 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,238 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —155,558 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —155,558 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code D | —22,238 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,238 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | APMD ApnimedBiotechnology | SEC FORM 4 Bought | $200K12,500 at $16.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —155,558 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | APMD Apnimedoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,238 at $0.00 | filing |
News
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026APMD · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Paul J. Sekhri; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.